2nd Green Rush Is Here
Keep your eye on this crazy good pot stock and get ready for the next green wave!

NYSE:ACB - Aurora Cannabis Stock Price Target and Predictions

  • Consensus Rating: Hold
  • Consensus Price Target: $10.93
  • Forecasted Upside: 42.83 %
  • Number of Analysts: 15
  • Breakdown:
  • 6 Sell Ratings
  • 9 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$7.65
▼ -0.54 (-6.59%)
1 month | 3 months | 12 months
Get New Aurora Cannabis Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ACB and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ACB

i We calculate consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). Our consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. Our consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
$10.93
▲ +42.83% Upside Potential
This price target is based on 15 analysts offering 12 month price targets for Aurora Cannabis in the last 3 months. The average price target is $10.93, with a high forecast of $18.00 and a low forecast of $3.60. The average price target represents a 42.83% upside from the last price of $7.65.
The #1 Way to Play the CBD Sector
A proprietary product line, unmatched distribution formula, and exponential growth potential in an explosive industry makes this company the top way to play the legal cannabis sector
Hold
The current consensus among 15 polled investment analysts is to hold stock in Aurora Cannabis. This Hold consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

  • 0 strong buy ratings
  • 1 buy ratings
  • 7 hold ratings
  • 6 sell ratings
10/29/2019
  • 0 strong buy ratings
  • 1 buy ratings
  • 9 hold ratings
  • 6 sell ratings
1/27/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 7 sell ratings
4/26/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 8 hold ratings
  • 8 sell ratings
7/25/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 8 sell ratings
10/23/2020
  • 0 strong buy ratings
  • 0 buy ratings
  • 10 hold ratings
  • 7 sell ratings
1/21/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 6 sell ratings
3/22/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 6 sell ratings
4/21/2021

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 9 hold ratings
  • 6 sell ratings

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/5/2021CIBCLower Price TargetNeutral$18.50 ➝ $15.00Low
i
2/16/2021CIBCBoost Price TargetNeutral$17.00 ➝ $18.50Low
i
2/12/2021Canaccord GenuityBoost Price TargetNeutral ➝ Hold$11.00 ➝ $14.00Low
i
2/12/2021MKM PartnersDowngradeNeutral ➝ SellLow
i
2/12/2021Needham & Company LLCDowngradeHold ➝ UnderperformLow
i
2/12/2021Cantor FitzgeraldBoost Price TargetNeutral$17.00 ➝ $18.00Low
i
Rating by P. Zuanic at Cantor Fitzgerald
2/12/2021DesjardinsDowngradeHold ➝ SellLow
i
2/8/2021CIBCBoost Price TargetNeutral$15.00 ➝ $17.00High
i
2/5/2021Cantor FitzgeraldBoost Price TargetNeutral$16.00 ➝ $17.00Low
i
Rating by P. Zuanic at Cantor Fitzgerald
1/25/2021Cantor FitzgeraldBoost Price TargetNeutral$12.00 ➝ $16.00Medium
i
Rating by P. Zuanic at Cantor Fitzgerald
1/4/2021Jefferies Financial GroupReiterated RatingUnderperform$4.59N/A
i
12/17/2020BMO Capital MarketsDowngradeMarket Perform ➝ Underperform$9.00Low
i
11/16/2020Atb Cap MarketsUpgradeUnderperform ➝ Sector PerformLow
i
Rating by D. Kideckel at Atb Cap Markets
11/16/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$5.56 ➝ $3.75Low
i
11/11/2020Stifel NicolausDowngradeHold ➝ SellN/A
i
Rating by W. Andrew Carter at Stifel Nicolaus
11/10/2020CIBCBoost Price TargetNeutral$12.00 ➝ $15.00Low
i
11/10/2020Canaccord GenuityBoost Price TargetHold$8.50 ➝ $11.00Low
i
11/9/2020Atb Cap MarketsDowngradeSector Perform ➝ UnderperformMedium
i
Rating by D. Kideckel at Atb Cap Markets
11/9/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$13.00 ➝ $12.00High
i
Rating by P. Zuanic at Cantor Fitzgerald
10/28/2020Stifel NicolausLower Price TargetHold$10.50 ➝ $3.60Medium
i
Rating by W. Andrew Carter at Stifel Nicolaus
10/27/2020Cantor FitzgeraldDowngradeOverweight ➝ Neutral$18.00 ➝ $7.00High
i
Rating by Pablo Zuanic at Cantor Fitzgerald
9/24/2020CIBCLower Price TargetNeutral$20.00 ➝ $12.00Low
i
9/23/2020CowenReiterated RatingHold$10.00Low
i
9/23/2020Cantor FitzgeraldBoost Price TargetOverweight$17.50 ➝ $18.00High
i
Rating by Pablo Zuanic at Cantor Fitzgerald
9/23/2020Needham & Company LLCReiterated RatingHoldHigh
i
Rating by Matt McGinley at Needham & Company LLC
9/23/2020Piper SandlerLower Price TargetNeutral$10.00 ➝ $8.00High
i
9/22/2020Canaccord GenuityLower Price TargetHold$21.00 ➝ $10.00High
i
9/21/2020Jefferies Financial GroupUpgradeUnderperform ➝ HoldHigh
i
9/9/2020Stifel NicolausLower Price TargetPositive ➝ Hold$16.00 ➝ $10.50High
i
Rating by W. Andrew Carter at Stifel Nicolaus
9/9/2020Cantor FitzgeraldLower Price TargetOverweight$29.00 ➝ $17.50Low
i
Rating by Pablo Zuanic at Cantor Fitzgerald
9/8/2020Needham & Company LLCReiterated RatingHoldHigh
i
Rating by Matt McGinley at Needham & Company LLC
9/8/2020LADENBURG THALM/SH SHDowngradeBuy ➝ Neutral$9.00High
i
8/18/2020CIBCLower Price TargetNeutral$24.00 ➝ $20.00Low
i
6/24/2020Cantor FitzgeraldBoost Price TargetOverweight$27.00 ➝ $29.00Medium
i
Rating by Pablo Zuanic at Cantor Fitzgerald
6/24/2020Stifel NicolausUpgradeSell ➝ Hold$6.20 ➝ $17.50Low
i
6/23/2020Needham & Company LLCInitiated CoverageHoldLow
i
Rating by Matt McGinley at Needham & Company LLC
5/22/2020CIBCBoost Price TargetNeutral$14.00 ➝ $24.00Low
i
5/22/2020Jefferies Financial GroupDowngradeHold ➝ Underperform$12.00 ➝ $14.00Medium
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
5/21/2020Cantor FitzgeraldBoost Price TargetMarket Perform ➝ Overweight$22.00 ➝ $27.00High
i
Rating by Pablo Zuanic at Cantor Fitzgerald
5/19/2020MKM PartnersInitiated CoverageHold$18.00High
i
Rating by William Kirk at MKM Partners
5/18/2020CIBCReiterated RatingBuy ➝ Market Perform$27.00 ➝ $14.00High
i
5/15/2020Pi FinancialReiterated RatingNeutralHigh
i
Rating by J. Zandberg at Pi Financial
5/15/2020DesjardinsUpgradeBuyHigh
i
Rating by John Chu at Desjardins
5/15/2020Piper SandlerUpgradeUnderweight ➝ Neutral$12.00 ➝ $10.00High
i
Rating by Michael Lavery at Piper Sandler
5/13/2020Cantor FitzgeraldBoost Price TargetOverweight$22.00High
i
Rating by Pablo Zuanic at Cantor Fitzgerald
5/12/2020Eight CapitalReiterated RatingHold$11.00High
i
4/13/2020Cantor FitzgeraldLower Price TargetOverweight$45.60 ➝ $33.00Low
i
Rating by Pablo Zuanic at Cantor Fitzgerald
4/13/2020Needham & Company LLCReiterated RatingHoldHigh
i
Rating by Matt McGinley at Needham & Company LLC
2/27/2020Bryan, Garnier & CoDowngradeNeutral ➝ SellLow
i
2/25/2020Needham & Company LLCInitiated CoverageHold$18.00High
i
2/24/2020Cantor FitzgeraldBoost Price TargetOverweight$45.00 ➝ $45.60Low
i
Rating by Pablo Zuanic at Cantor Fitzgerald
2/24/2020CowenDowngradeOutperform ➝ Market Perform$72.00 ➝ $30.00Medium
i
2/16/2020Pi FinancialReiterated RatingHold$24.00High
i
Rating by Jason Zandberg at Pi Financial
2/16/2020CIBCReiterated RatingHold$27.00High
i
Rating by John Zamparo at CIBC
2/14/2020MKM PartnersUpgradeSell ➝ NeutralLow
i
Rating by William Kirk at MKM Partners
2/14/2020Canaccord GenuityReiterated RatingHold$27.00Low
i
Rating by Matt Bottomley at Canaccord Genuity
2/10/2020CIBCReiterated RatingHold$30.00High
i
Rating by John Zamparo at CIBC
2/7/2020Pi FinancialDowngradeHold$24.00High
i
Rating by Jason Zandberg at Pi Financial
2/7/2020Eight CapitalDowngradeBuy ➝ NeutralLow
i
2/7/2020Cantor FitzgeraldLower Price TargetOverweight$60.00 ➝ $45.00Low
i
Rating by Pablo Zuanic at Cantor Fitzgerald
2/7/2020Compass PointLower Price TargetNeutral$60.00 ➝ $24.00High
i
Rating by Rommel Dionisio at Compass Point
2/7/2020Canaccord GenuityDowngradeBuy ➝ HoldLow
i
Rating by Matt Bottomley at Canaccord Genuity
2/6/2020Jefferies Financial GroupDowngradeHoldHigh
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
1/10/2020Piper Jaffray CompaniesDowngradeNeutral ➝ Underweight$36.00 ➝ $12.00Low
i
Rating by Michael Lavery at Piper Jaffray Companies
1/10/2020Bank of AmericaDowngradeNeutral ➝ Underperform$12.00High
i
1/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$36.00 ➝ $12.00High
i
12/31/2019Jefferies Financial GroupDowngradeHold$36.00High
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
12/23/2019MKM PartnersReiterated RatingSell$36.00 ➝ $24.00Medium
i
Rating by William Kirk at MKM Partners
12/23/2019Jefferies Financial GroupDowngradeBuy ➝ Hold$36.00Medium
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
11/26/2019Cantor FitzgeraldReiterated RatingBuy$52.80Low
i
Rating by Pablo Zuanic at Cantor Fitzgerald
11/15/2019MKM PartnersDowngradeHold$42.00 ➝ $36.00High
i
Rating by William Kirk at MKM Partners
11/15/2019Cantor FitzgeraldUpgradeNeutral ➝ Overweight$61.20 ➝ $70.20High
i
Rating by P. Zuanic at Cantor Fitzgerald
11/15/2019Piper Jaffray CompaniesLower Price TargetNeutral$48.00 ➝ $36.00High
i
Rating by Michael Lavery at Piper Jaffray Companies
11/4/2019Cantor FitzgeraldInitiated CoverageNeutral$61.20High
i
Rating by P. Zuanic at Cantor Fitzgerald
10/22/2019Piper Jaffray CompaniesLower Price TargetNeutral$84.00 ➝ $48.00Medium
i
Rating by Michael Lavery at Piper Jaffray Companies
10/15/2019Pi FinancialSet Price TargetBuy$84.00High
i
Rating by Jason Zandberg at Pi Financial
10/11/2019Jefferies Financial GroupSet Price TargetBuy$84.00Low
i
Rating by Owen Bennett at Jefferies Financial Group Inc.
9/24/2019CIBCInitiated CoverageNeutral$84.00High
i
9/20/2019MKM PartnersDowngradeSellLow
i
9/19/2019MKM PartnersInitiated CoverageBuy$60.00Medium
i
9/13/2019Canaccord GenuitySet Price TargetBuy$162.00Medium
i
Rating by Matt Bottomley at Canaccord Genuity
9/13/2019Piper Jaffray CompaniesSet Price TargetHold$84.00High
i
Rating by Michael Lavery at Piper Jaffray Companies
9/12/2019Compass PointSet Price TargetHold$96.00High
i
Rating by Rommel Dionisio at Compass Point
9/12/2019Stifel NicolausReiterated RatingHold ➝ Sell$84.00 ➝ $60.00High
i
Rating by W. Andrew Carter at Stifel Nicolaus
8/12/2019Piper Jaffray CompaniesInitiated CoverageNeutral ➝ Neutral$84.00Low
i
7/18/2019Bank of AmericaDowngradeBuy ➝ Neutral$87.60High
i
7/17/2019LADENBURG THALM/SH SHInitiated CoverageBuy ➝ Buy$108.00Medium
i
7/8/2019Compass PointInitiated CoverageNeutral ➝ NeutralMedium
i
6/5/2019Stifel NicolausInitiated CoverageHold ➝ HoldMedium
i
4/25/2019DesjardinsInitiated CoverageBuy ➝ Buy$108.84Low
i
Rating by J. Chu at Desjardins
4/17/2019Bank of AmericaInitiated CoverageBuy ➝ Buy$132.00Medium
i
3/13/2019GMP SecuritiesUpgradeHold ➝ BuyHigh
i
3/5/2019CowenInitiated CoverageOutperformHigh
i
2/25/2019Jefferies Financial GroupInitiated CoverageBuy ➝ BuyHigh
i
2/21/2019Seaport Global SecuritiesInitiated CoverageNeutral ➝ NeutralLow
i
Rating by B. Hundley at Seaport Global Securities
2/12/2019GMP SecuritiesReiterated RatingHold$114.00High
i
11/10/2017Canaccord GenuityReiterated RatingBuy$53.40N/A
i
(Data available from 4/21/2016 forward)
Aurora Cannabis logo
Aurora Cannabis Inc. produces and distributes medical cannabis products worldwide. It is vertically integrated and horizontally diversified across various segments of the cannabis value chain, including facility engineering and design, cannabis breeding, genetics research, production, derivatives, high value-add product development, home cultivation, wholesale, and retail distribution. The company produces various strains of dried cannabis, cannabis oil and capsules, and topical kits for medical patients. It also sells vaporizers; consumable vaporizer accessories, including valves, screens, etc.; and herb mills for using CanniMed herbal cannabis products, as well as grinders and vaporizer lockable containers. In addition, the company engages in the development of medical cannabis products at various stages of development, including oral, topical, edible, and inhalable products; and operation of CanvasRX, a network of cannabis counseling and outreach centers. Further, it provides patient counselling services; design and construction services; and cannabis analytical product testing services. The company's brand portfolio includes Aurora, Aurora Drift, San Rafael '71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, Woodstock, and ROAR Sports. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.
Read More

Today's Range

Now: $7.65
$7.61
$8.37

50 Day Range

MA: $9.40
$7.79
$11.14

52 Week Range

Now: $7.65
$3.71
$19.68

Volume

9,228,826 shs

Average Volume

20,869,936 shs

Market Capitalization

$1.51 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.44

Frequently Asked Questions

What sell-side analysts currently cover shares of Aurora Cannabis?

The following Wall Street analysts have issued research reports on Aurora Cannabis in the last twelve months: Atb Cap Markets, BMO Capital Markets, Canaccord Genuity, Cantor Fitzgerald, CIBC, Cowen Inc, Desjardins, Eight Capital, Jefferies Financial Group Inc., LADENBURG THALM/SH SH, MKM Partners, Needham & Company LLC, Pi Financial, Piper Sandler, Stifel Nicolaus, and Zacks Investment Research.
View the latest analyst ratings for ACB.

What is the current price target for Aurora Cannabis?

11 Wall Street analysts have set twelve-month price targets for Aurora Cannabis in the last year. Their average twelve-month price target is $10.93, suggesting a possible upside of 42.8%. MKM Partners has the highest price target set, predicting ACB will reach $18.00 in the next twelve months. Stifel Nicolaus has the lowest price target set, forecasting a price of $3.60 for Aurora Cannabis in the next year.
View the latest price targets for ACB.

What is the current consensus analyst rating for Aurora Cannabis?

Aurora Cannabis currently has 6 sell ratings and 9 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Hold." A "hold" rating indicates that analysts believe investors should keep any existing positions they have in ACB, but not buy more shares or sell existing shares.
View the latest ratings for ACB.

What other companies compete with Aurora Cannabis?

How do I contact Aurora Cannabis' investor relations team?

Aurora Cannabis' physical mailing address is 10355 JASPER AVENUE SUITE 500, EDMONTON A0, T5J 1Y6. The company's listed phone number is 1-855-279-4652 and its investor relations email address is [email protected] The official website for Aurora Cannabis is auroramj.com.

Could This Magic Mushroom Really Spark A New $16 Billion Industry?
This just in! Strange laboratory creates psychedelic breakthrough... and could spark a new megatrend that every investor needs to know about!